Skip to main content

Table 1 Patient characteristics

From: FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by 90yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases

  Number of patients = 9
Male/Female 3/6
Median Age (Range) 63 (46-77) years
Disease stage at diagnosis at start of FCR
   I 1 0
   II 1 5
   III 1 3
   IV 6 1
Bone marrow involvement   
0% 7
   10% to ≤ 25% 2
Extranodal involvement 1 (liver)
FLIPI   
Low 1
Low-intermediate 6
Intermediate-high 2
Bulky disease 1
B-symptoms 0
Prior therapy including rituximab   
No 2
Yes 7
Number of previous regimens   
1 2
2 5
>2 2